Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

  Lionel Adès ¹ AuthorId : 479696
Author

  Xavier Thomas ^{2, 3} AuthorId : 64675
Author

  Agnes Cuerci-Bres AuthorId : 1323227
Author

  Raffoux Emmanuel AuthorId : 1323228
Author

  Olivier Spertini AuthorId : 1254863
Author

  Norbert Vey ⁴ AuthorId : 464620
Author

  Thierry Lamy ^{5, 6} AuthorId : 464262
Author

  Christian Récher ^{7, 8, 9} AuthorId : 881122
Author

  Arnaud Pigneux ¹⁰ AuthorId : 479697
Author

  Dominique Bordessoule ^{11, 12} AuthorId : 93818

Author

  Eric Deconincki AuthorId : 1323229
Author

  Claude Cardin AuthorId : 1323230
Author

  Olivier Tournilhac ^{13, 14} AuthorId : 366717
Author

  Jean-François Lambert AuthorId : 89790
Author

  Patrice Chevallier ¹⁵ AuthorId : 464614
Author

  Stephane De Botton AuthorId : 1323231
Author

  Julie Lejeune ¹⁶ AuthorId : 336017
Author

  Hervé Dombret ^{17, 18} AuthorId : 304945
Author

  Sylvie Chevret ¹⁹ AuthorId : 92360
Author

  Pierre Fenaux ¹⁸ AuthorId : 802350
Author